Vaxart Inc
F:NB11
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vaxart Inc
F:NB11
|
US |
|
V
|
Vishay Intertechnology Inc
DUS:VHY
|
US |
|
Viper Energy Partners LP
F:VEG
|
US |
|
N
|
NRG Energy Inc
F:NRA
|
US |
|
Discovery Ltd
F:D3H
|
ZA |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
I
|
Inspecs Group PLC
F:4GV
|
UK |
|
F
|
Forvia SE
XMUN:FAU
|
FR |
|
Mauna Kea Technologies SA
F:1MK
|
FR |
|
F
|
Fresenius SE & Co KGaA
F:FRE
|
DE |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
|
Atlanta Braves Holdings Inc
F:E45
|
US |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
O
|
Osaka Gas Co Ltd
DUS:OSA
|
JP |
Wall St Price Targets
NB11 Price Targets Summary
Vaxart Inc
According to Wall Street analysts, the average 1-year price target for NB11 is 2.42 EUR with a low forecast of 2.4 EUR and a high forecast of 2.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NB11's stock price target?
Price Target
2.42
EUR
According to Wall Street analysts, the average 1-year price target for NB11 is 2.42 EUR with a low forecast of 2.4 EUR and a high forecast of 2.49 EUR.
What is the Revenue forecast for Vaxart Inc?
Projected CAGR
-9%
Over the last 7 years, the compound annual growth rate for Revenue has been 78%. The projected CAGR for the next 7 years is -9%.
What is the Operating Income forecast for Vaxart Inc?
Projected CAGR
-5%
The compound annual growth rate for Operating Income over the next 7 years is -5%.
